Santen Fortifies Glaucoma Strategy With Sepetaprost Japan Filing

 
• By Lisa Takagi
  
Santen applied for sepetaprost's global first approval in Japan for glaucoma.
Santen seeks global first approval in Japan for sepetaprost in glaucoma. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Ophthalmology